| Kobo Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531541 |
NSE Symbol : - |
P/E(TTM) : - |
|
ISIN Demat : INE881A01015 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : -55.79 |
Market Cap(₹Cr) : 10.36 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.02 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Total Income | 0.02 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Total Expenditure | 0.34 | 0.25 | 0.20 | 0.20 | 0.23 | 0.79 |
| PBIDT | -0.32 | -0.25 | -0.20 | -0.20 | -0.21 | -0.79 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | -0.32 | -0.25 | -0.20 | -0.20 | -0.21 | -0.79 |
| Depreciation | 1.01 | 1.01 | 1.03 | 1.02 | 1.01 | 1.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -1.33 | -1.26 | -1.23 | -1.22 | -1.23 | -1.79 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -1.33 | -1.26 | -1.23 | -1.22 | -1.23 | -1.79 |
| EPS (Unit Curr.) | -0.56 | -0.53 | -0.52 | -0.51 | -0.51 | -0.75 |
| EPS (Adj) (Unit Curr.) | -0.56 | -0.53 | -0.52 | -0.51 | -0.51 | -0.75 |
| Calculated EPS (Unit Curr.) | -0.56 | -0.53 | -0.52 | -0.51 | -0.51 | -0.75 |
| Calculated EPS (Adj) (Unit Curr.) | -0.56 | -0.53 | -0.52 | -0.51 | -0.51 | -0.75 |
| Calculated EPS (Ann.) (Unit Curr.) | -2.23 | -2.11 | -2.07 | -2.04 | -2.06 | -3.01 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -2.23 | -2.11 | -2.07 | -2.04 | -2.06 | -3.01 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 | 23.83 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PATM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |